Left-handedness, learning disability, autoimmune disease, and seizure history influence age at onset and phenotypical targeting of Alzheimer's disease

Background: Risk factors associated with sporadic non-amnestic and early-onset Alzheimer's disease remain underexamined. We investigated a large, clinically heterogeneous Alzheimer's disease cohort for frequencies of established Alzheimer's disease risk factors (hypertension, hyperlipidemia, diabetes mellitus, APOE-{epsilon}4 frequency, and years of education), alongside a suite of novel factors with historical theoretical association (non-right-handedness, learning disability, seizures, and autoimmune disease). Methods: In this case-control study, we screened the demographic and health histories of 750 consecutive early-onset and 750 late-onset Alzheimer's disease patients from the University of California San Francisco Memory and Aging Center for the prevalence of conventional risk and novel Alzheimer's disease factors and compared these results with 8,859 Alzheimer's disease individuals from the National Alzheimer's Coordinating Center, Amsterdam University Medical Center, Amsterdam, and Mayo Clinic, Jacksonville. Results: Early-onset Alzheimer's disease was associated with significantly lower frequencies of established risk factors (hypertension, hyperlipidemia, diabetes mellitus, all p<0.001, APOE-{epsilon}4, p=0.03) and significantly higher frequencies of novel factors (non-right-handedness, learning disability, active seizure, all p<0.001, remote seizure, p=0.002, and autoimmune disease, p=0.007). Logistic regressions predicting EOAD vs. LOAD controlling for sex, education, APOE-{epsilon}4 status, typical, and novel risk factors, produced findings consistent with the above. Principal component analysis loaded novel factors into two components, non-right-handedness and learning disability versus seizure and autoimmune disease, and the combination of factors from both components resulted in an exponential decrease in age at onset from any single factor alone. APOE-{epsilon}4 provided no additional contribution to age at onset decreases within the non-amnestic Alzheimer's disease cohort but shifted the age of onset 3 years earlier within amnestic presentations (p=0.013). Conclusions: We identified non-right-handedness, learning disability, seizures, and autoimmune disease as novel factors that affect both the age at onset and phenotypical targeting of Alzheimer's disease. Together these results support a new theoretical framework of neurodegenerative disease susceptibility and that through the collection of detailed developmental and health history, neurodegenerative disease risk in some may be highly predictable, offering new opportunities towards early detection, monitoring, therapeutic intervention, and ultimately disease prevention.

[1]  Mark Rubin,et al.  When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing , 2021, Synthese.

[2]  Young Ho Park,et al.  Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis , 2019, Neurobiology of Aging.

[3]  J. Marchini,et al.  Handedness, language areas and neuropsychiatric diseases: insights from brain imaging and genetics , 2019, Brain : a journal of neurology.

[4]  D. Knopman,et al.  Systemic inflammation during midlife and cognitive change over 20 years , 2019, Neurology.

[5]  W. Ray,et al.  The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease , 2019, Front. Aging Neurosci..

[6]  Mercedes F. Paredes,et al.  Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia , 2019, Brain communications.

[7]  Charles Mock,et al.  Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set , 2018, Alzheimer disease and associated disorders.

[8]  M. Gorno-Tempini,et al.  Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy , 2018, JAMA neurology.

[9]  P. Scheltens,et al.  Neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease , 2018, Journal of Neuroinflammation.

[10]  L. Piccio,et al.  The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity , 2018, Immunity.

[11]  J. Grutzendler,et al.  Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging , 2018, Biological Psychiatry.

[12]  B. Wollscheid,et al.  Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex , 2018, Journal of Neuroinflammation.

[13]  J. Rinne,et al.  Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later , 2017, JAMA neurology.

[14]  Nick C. Fox,et al.  Consensus classification of posterior cortical atrophy , 2017, Alzheimer's & Dementia.

[15]  C. Kawas,et al.  Dementia in the oldest old: Beyond Alzheimer disease , 2017, PLoS medicine.

[16]  M. Goldacre,et al.  Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK , 2017, Journal of Epidemiology & Community Health.

[17]  Nick C. Fox,et al.  Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease , 2016, Alzheimer's & Dementia.

[18]  S. Gautam,et al.  Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis , 2016, CNS Drugs.

[19]  W. Guan,et al.  FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis , 2016, Human Genetics.

[20]  C. Kawas,et al.  Multiple pathologies are common and related to dementia in the oldest-old , 2015, Neurology.

[21]  K. Langa,et al.  Is the risk of Alzheimer’s disease and dementia declining? , 2015, Alzheimer's Research & Therapy.

[22]  J. Álvarez-Sabín,et al.  Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? , 2015, Journal of Neurology.

[23]  S. Hider,et al.  Association of Polymyalgia Rheumatica With Socioeconomic Status in Primary Care: A Cross-Sectional Observational Study , 2014, Arthritis care & research.

[24]  Xue Hua,et al.  Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. , 2014, JAMA neurology.

[25]  Z. Vadasz,et al.  Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases , 2014, Clinical Reviews in Allergy & Immunology.

[26]  K. Rankin,et al.  Handedness and language learning disability differentially distribute in progressive aphasia variants. , 2013, Brain : a journal of neurology.

[27]  Dror G. Feitelson,et al.  Comparing Performance Heatmaps , 2013, JSSPP.

[28]  D. Geschwind,et al.  TDP-43 frontotemporal lobar degeneration and autoimmune disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  Orrin Devinsky,et al.  Epilepsy Associated with Systemic Autoimmune Disorders , 2013, Epilepsy currents.

[30]  J. Egido,et al.  Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice. , 2012, Brain : a journal of neurology.

[31]  S. Vesely,et al.  Prevalence of primary immune thrombocytopenia in Oklahoma , 2012, American journal of hematology.

[32]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[33]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[34]  Nick C Fox,et al.  Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.

[35]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[36]  I. Mcmanus,et al.  Science in the Making: Right Hand, Left Hand. III: Estimating historical rates of left-handedness , 2010, Laterality.

[37]  J. Olsen,et al.  Autoimmune disease and risk for Parkinson disease , 2009, Neurology.

[38]  L. Boulanger,et al.  Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.

[39]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[40]  Andrew Gelman,et al.  Why We (Usually) Don't Have to Worry About Multiple Comparisons , 2009, 0907.2478.

[41]  M. Snowling,et al.  A Brief History of Dyslexia , 2008 .

[42]  Atlanta,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.

[43]  Ken Kleinman,et al.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  I. Palamaras,et al.  Lifetime prevalence distribution of chronic discoid lupus erythematosus , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[45]  Joylee Wu,et al.  The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set , 2007, Alzheimer disease and associated disorders.

[46]  C. Kawas,et al.  Alzheimer's and dementia in the oldest-old: a century of challenges. , 2006, Current Alzheimer research.

[47]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[48]  D. Margolis,et al.  Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. , 2005, Archives of dermatology.

[49]  C. Kreibich,et al.  Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.

[50]  T. Takai Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.

[51]  Fernando Gomollón Celiac sprue. , 2002, The New England journal of medicine.

[52]  M. Mehler,et al.  Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat , 2000, Trends in Neurosciences.

[53]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[54]  G C Roman,et al.  Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.

[55]  K. Boberg,et al.  Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. , 1998, Scandinavian journal of gastroenterology.

[56]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[57]  M. Cotch,et al.  The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. , 1996, Arthritis and rheumatism.

[58]  L. Phillips The Epidemiology of Myasthenia Gravis , 2003, Neurologic clinics.

[59]  M. Albert,et al.  Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. , 1994, Archives of neurology.

[60]  P Jallon,et al.  Pathological left-handedness. Left-handedness correlatives in adult epileptics. , 1993, Brain : a journal of neurology.

[61]  R. Kuljiš,et al.  Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. , 1993, Journal of neuroimmunology.

[62]  N. Bagchi,et al.  Thyroid dysfunction in adults over age 55 years. A study in an urban US community. , 1990, Archives of internal medicine.

[63]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research. , 1985, Archives of neurology.

[64]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: III. A hypothesis and a program for research. , 1985, Archives of neurology.

[65]  B. Seltzer,et al.  Left‐handedness in early and late onset dementia , 1984, Neurology.

[66]  P. Satz,et al.  Pathological left-handedness: an explanatory model. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.